14001-70-8 Usage
Description
Pyrimidine, 2-(methylthio)-5-nitro(8CI,9CI) is a pyrimidine derivative characterized by the presence of a methylthio group and a nitro group attached to the pyrimidine ring. It is a chemical compound that may have potential applications in various fields, including pharmaceuticals and agrochemicals, depending on further research and studies on its chemical and biological properties.
Uses
Used in Pharmaceutical Industry:
Pyrimidine, 2-(methylthio)-5-nitro(8CI,9CI) is used as a pharmaceutical compound for its potential therapeutic applications. Its unique chemical structure allows it to interact with biological targets, making it a promising candidate for the development of new drugs.
Used in Agrochemical Industry:
Pyrimidine, 2-(methylthio)-5-nitro(8CI,9CI) is used as an agrochemical compound for its potential applications in crop protection and enhancement. Its chemical properties may contribute to the development of new pesticides, herbicides, or other agrochemical products that can improve agricultural productivity and sustainability.
Note: The specific applications and reasons for using Pyrimidine, 2-(methylthio)-5-nitro(8CI,9CI) in different industries are not explicitly mentioned in the provided materials. The uses listed above are inferred based on the general potential of pyrimidine derivatives in these industries. Further research and studies are required to confirm the specific applications and benefits of this compound.
Check Digit Verification of cas no
The CAS Registry Mumber 14001-70-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,0,0 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 14001-70:
(7*1)+(6*4)+(5*0)+(4*0)+(3*1)+(2*7)+(1*0)=48
48 % 10 = 8
So 14001-70-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H5N3O2S/c1-11-5-6-2-4(3-7-5)8(9)10/h2-3H,1H3
14001-70-8Relevant articles and documents
GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
-
Page/Page column 56-57, (2009/12/28)
Compounds of Formula I wherein R1, R2, X, and Y are as defined herein, or a tautomer, optical isomer, prodrug, co-crystal, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
